$CODA
Coda Octopus Group, Inc. Stock $coda

$coda Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223002840 Filed on January 30, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$5.596M	$5.135M	$22.23M
YoY Change	-4.14%	1.08%	4.19%
Cost Of Revenue	$1.843M	$1.699M	$7.035M
YoY Change	9.83%	7.0%	7.21%
Gross Profit	$3.753M	$3.436M	$15.19M
YoY Change	-9.78%	-1.61%	2.85%
Gross Profit Margin	67.06%	66.92%	68.35%
Selling, General & Admin	$1.962M	$1.833M	$7.949M
YoY Change	-7.04%	-13.43%	0.42%
% of Gross Profit	52.29%	53.33%	52.33%
Research & Development	$444.5K	$469.7K	$2.238M
YoY Change	-33.95%	-56.45%	-24.97%
% of Gross Profit	11.84%	13.67%	14.73%
Depreciation & Amortization	$164.0K	$85.97K	$678.7K
YoY Change	1.57%	-10.97%	-26.56%
% of Gross Profit	4.37%	2.5%	4.47%
Operating Expenses	$2.407M	$2.302M	$10.19M
YoY Change	-13.55%	-27.95%	-6.53%
Operating Profit	$1.346M	$1.134M	$5.004M
YoY Change	-2.17%	281.44%	29.25%
Interest Expense	$0.00	-$6.800K	-$9.700K
YoY Change	-100.0%	-36.51%	-81.91%
% of Operating Profit	0.0%	-0.6%	-0.19%
Other Income/Expense, Net	$15.77K	$23.74K	$128.3K
YoY Change	-80.29%	-96.66%	-91.06%
Pretax Income	$1.362M	$1.151M	$5.132M
YoY Change	-5.73%	15.33%	-2.3%
Income Tax	-$36.00K	$447.0K	$831.1K
% Of Pretax Income	-2.64%	38.84%	16.19%
Net Earnings	$1.398M	$704.0K	$4.301M
YoY Change	14.84%	683.1%	-13.07%
Net Earnings / Revenue	24.98%	13.71%	19.35%
Basic Earnings Per Share	$0.13		$0.40
Diluted Earnings Per Share	$0.12	$63.99K	$0.38
COMMON SHARES
Basic Shares Outstanding	10.94M shares		10.86M shares
Diluted Shares Outstanding	11.38M shares		11.28M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$24.52M	$22.93M	$22.93M
YoY Change	18.4%	29.19%	29.19%
Cash & Equivalents	$24.52M	$22.93M
Short-Term Investments		$0.00
Other Short-Term Assets	$431.8K	$343.1K	$259.1K
YoY Change	24.72%	-72.91%	-79.54%
Inventory	$11.18M	$10.03M	$10.03M
Prepaid Expenses	$381.0K	$240.5K
Receivables	$3.143M	$2.871M	$3.473M
Other Receivables	$267.6K	$324.4K	$324.4K
Total Short-Term Assets	$40.31M	$37.01M	$37.01M
YoY Change	15.91%	4.09%	4.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.072M	$5.833M	$5.833M
YoY Change	-9.97%	-3.39%	-3.39%
Goodwill		$3.382M
YoY Change		0.0%
Intangibles		$442.3K
YoY Change		7.28%
Long-Term Investments
YoY Change
Other Assets	$295.8K	$259.8K	$259.8K
YoY Change	241.44%	238.38%	238.38%
Total Long-Term Assets	$10.20M	$9.917M	$9.917M
YoY Change	-4.02%	0.09%	0.09%
TOTAL ASSETS
Total Short-Term Assets	$40.31M	$37.01M	$37.01M
Total Long-Term Assets	$10.20M	$9.917M	$9.917M
Total Assets	$50.50M	$46.93M	$46.93M
YoY Change	11.24%	3.22%	3.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.415M	$793.2K	$793.3K
YoY Change	342.61%	-45.47%	-45.47%
Accrued Expenses	$1.612M	$1.732M	$1.732M
YoY Change	100.13%	133.87%	133.87%
Deferred Revenue	$805.0K	$943.6K
YoY Change		-52.82%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Short-Term Liabilities	$3.832M	$3.469M	$3.469M
YoY Change	58.77%	-18.55%	-18.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$101.8K	$76.13K	$76.13K
YoY Change	-33.54%	-51.78%	-51.78%
Total Long-Term Liabilities	$101.8K	$76.13K	$76.13K
YoY Change	-33.54%	-51.78%	-51.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.832M	$3.469M	$3.469M
Total Long-Term Liabilities	$101.8K	$76.13K	$76.13K
Total Liabilities	$3.934M	$3.545M	$3.545M
YoY Change	53.26%	-19.74%	-19.74%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.78M	-$14.18M
YoY Change		-23.28%
Common Stock	$10.94K	$62.32M
YoY Change		1.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$28.34K	$28.34K
YoY Change
Treasury Stock Shares
Shareholders Equity	$46.57M	$43.38M	$43.38M
YoY Change
Total Liabilities & Shareholders Equity	$50.50M	$46.93M	$46.93M
YoY Change	11.24%	3.22%	3.22%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$1.398M	$704.0K	$4.301M
YoY Change	14.84%	683.1%	-13.07%
Depreciation, Depletion And Amortization	$164.0K	$85.97K	$678.7K
YoY Change	1.57%	-10.97%	-26.56%
Cash From Operating Activities	$984.9K	$444.4K	$6.727M
YoY Change	-71.55%	-222.87%	105.73%
INVESTING ACTIVITIES
Capital Expenditures	$84.42K	$639.3K	$466.5K
YoY Change	-108.43%	-609.14%	-148.38%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$105.9K	$639.3K	-$556.6K
YoY Change	-89.43%	-609.14%	-42.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			$63.56K
YoY Change			-87.53%
Cash From Financing Activities		-28.34K	-$91.90K
YoY Change		-78.16%	-165.96%
NET CHANGE
Cash From Operating Activities	$984.9K	444.4K	$6.727M
Cash From Investing Activities	-$105.9K	639.3K	-$556.6K
Cash From Financing Activities		-28.34K	-$91.90K
Net Change In Cash	$1.595M	1.055M	$5.180M
YoY Change	-33.43%	-271.04%	111.86%
FREE CASH FLOW
Cash From Operating Activities	$984.9K	$444.4K	$6.727M
Capital Expenditures	$84.42K	$639.3K	$466.5K
Free Cash Flow	$900.5K	-$194.9K	$6.260M
YoY Change	-79.83%	-17.48%	47.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001334325
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2022	CODA	Funding From Paycheck Protection Program Recognized As Income FundingFromPaycheckProtectionProgramRecognizedAsIncome		usd
CY2022	CODA	Proceeds From Paycheck Protection Program ProceedsFromPaycheckProtectionProgram		usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	CODA	Purchase Of Property And Equipment Previously Held In Escrow Included In Prepaid Expenses PurchaseOfPropertyAndEquipmentPreviouslyHeldInEscrowIncludedInPrepaidExpenses		usd
CY2022	CODA	Paycheck Protection Program Loans PaycheckProtectionProgramLoans		usd
CY2021Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable		usd
CY2020Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableOutstandingNumber		shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberGranted		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceGranted
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2021	CODA	Stock Issued During Period Shares Stock Options Vested StockIssuedDuringPeriodSharesStockOptionsVested		shares
CY2021	CODA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedNumberOfShares		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberForfeited		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceForfeited
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberGranted		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceGranted
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	CODA	Stock Issued During Period Shares Stock Options Vested StockIssuedDuringPeriodSharesStockOptionsVested		shares
CY2022	CODA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercised Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisedNumberOfShares		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceForfeited
CY2020Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNonvestedNumber		shares
CY2020Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageGrantDateFairValue
CY2020Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableNumber		shares
CY2020Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantsInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingVestedInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableVestedInPeriod		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisesInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableExercisesInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Treasury Stockin Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingTreasuryStockinPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Treasury Stock In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableTreasuryStockInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockInPeriod		shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableForfeitedInPeriod		shares
CY2021Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableNumber		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableGrantsInPeriod		shares
CY2022	dei	Security12b Title Security12bTitle	COMMON STOCK, $0.001 PAR VALUE PER SHARE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableVestedInPeriod		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingExercisesInPeriod		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesOutstandingWeightedAverageGrantDateFairValue
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableExercisesInPeriod		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises Weighted Average Grant Date Fair Value Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesWeightedAverageGrantDateFairValueExercisable
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesInPeriod		shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesWeightedAverageGrantDateFairValue
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableForfeitedInPeriod		shares
CY2022Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableNumber		shares
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic		usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome		usd
CY2022Q4	us-gaap	Notes Payable NotesPayable		usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent		usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-10-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--10-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38154
CY2022	dei	Entity Registrant Name EntityRegistrantName	CODA OCTOPUS GROUP, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	34-2008348
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	3300 S Hiawassee Rd
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 104-105
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32835
CY2022	dei	City Area Code CityAreaCode	407
CY2022	dei	Local Phone Number LocalPhoneNumber	735 2406
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	27144477	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10942353	shares
CY2022	dei	Auditor Name AuditorName	Frazier & Deeter, LLC
CY2022	dei	Auditor Location AuditorLocation	Tampa, Florida
CY2022	dei	Auditor Firm AuditorFirmId	215
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22927371	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17747656	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2870600	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4207996	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10027111	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	10691177	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	602115	usd
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1080384	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	240464	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1202327	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	343061	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	627619	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	37010722	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	35557159	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5832532	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6037101	usd
CY2022Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3824394	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3794383	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	259810	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	76776	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	4084204	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	3871159	usd
CY2022Q4	us-gaap	Assets Assets	46927458	usd
CY2021Q4	us-gaap	Assets Assets	45465419	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	793247	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1454611	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1731706	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	740449	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	63559	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	943569	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1999841	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3468522	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4258460	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	76127	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	157886	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	76127	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	157886	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3544649	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4416346	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10916853	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10916853	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10857195	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10857195	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10918	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	21331527	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	7035115	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	6561809	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10858	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	28337	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	62313988	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	61183131	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4737124	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1667059	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14176636	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18477857	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43382809	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41049073	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46927458	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45465419	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	22225803	usd
CY2022	us-gaap	Gross Profit GrossProfit	15190688	usd
CY2021	us-gaap	Gross Profit GrossProfit	14769718	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2237920	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2982676	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7948704	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7949525	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10186624	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	10932201	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	5004064	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	3837517	usd
CY2022	us-gaap	Other Income OtherIncome	137975	usd
CY2021	us-gaap	Other Income OtherIncome	1435382	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9704	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-19655	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	128271	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1415727	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5132335	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5253244	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1005140	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16592	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-174026	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	288887	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	831114	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	305479	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4947765	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10863674	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10804074	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11281347	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11309740	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4947765	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3070065	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	654219	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3070065	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	654219	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1231156	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5601984	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34396268	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	830071	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	220750	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	654219	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4947765	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	41049073	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1130917	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3070065	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	28337	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	43382809	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4947765	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	738729	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	924073	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1130917	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1050821	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-193083	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	485126	usd
CY2021	CODA	Funding From Paycheck Protection Program Recognized As Income FundingFromPaycheckProtectionProgramRecognizedAsIncome	-648872	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-992948	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2193336	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	675878	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1063163	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-447927	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	219084	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-165010	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	913123	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-275909	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	383449	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	533996	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	326761	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-990729	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	956251	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6726967	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3269770	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	466471	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	850894	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	90089	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	113310	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-556560	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-964204	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	63559	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	509549	usd
CY2021	CODA	Proceeds From Paycheck Protection Program ProceedsFromPaycheckProtectionProgram	648872	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	28337	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-91896	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	139323	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-898796	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	168478	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5179715	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2613367	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17747656	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	15134289	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22927371	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	17747656	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	9704	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	19655	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	74432	usd
CY2022	CODA	Purchase Of Property And Equipment Previously Held In Escrow Included In Prepaid Expenses PurchaseOfPropertyAndEquipmentPreviouslyHeldInEscrowIncludedInPrepaidExpenses	694664	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	295345	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	442286	usd
CY2022Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableOutstandingNumber	159003	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.65
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	148164	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.65
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2424340	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2246139	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	10027111	usd
CY2021Q4	CODA	Depreciation Cost Of Goods Sold Allocation Percentage DepreciationCostOfGoodsSoldAllocationPercentage	0.70	pure
CY2022	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	5042	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	183668	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4.65
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	36667	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.65
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7219344	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	7525419	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	383427	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	919619	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	10691177	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zkM7k31jFU2b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">g. <span id="xdx_866_zv25FPNBZcRd">Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues including unbilled and deferred revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include estimates related to the percentage of completion method used to account for contracts including costs and earnings in excess of billings, billings in excess of costs and estimated earnings, the valuation of the deferred tax asset, and the valuation of goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0	usd
CY2021Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	0	usd
CY2022	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	0	usd
CY2021	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	3884	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zO8DdR1LezQb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <span id="xdx_86C_zpUlKThsmti4">Concentrations of Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit losses, if any, have been provided for in the consolidated financial statements and are based on management’s expectations. The Company’s accounts receivables are subject to potential concentrations of credit risk, since a significant part of the Company’s sales are to a small number of companies and, even though these are generally established businesses, market fluctuations such as the price of oil may affect our customers’ ability to meet their obligations to us. Furthermore, Trade disputes may result in impairment or delays in receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s bank deposits are held with financial institutions both in and outside the USA. At times, such amounts may be in excess of applicable government mandated insurance limits. The Company has not experienced any losses in such accounts or lack of access to its cash, and believes it is not exposed to significant risk of loss with respect to cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	602115	usd
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	1080384	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	790458	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1879790	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	229238	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	277937	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2022	us-gaap	Other Income OtherIncome	137975	usd
CY2021	us-gaap	Other Income OtherIncome	1435382	usd
CY2022	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	Customer relationships, non-compete agreements, patents and licenses are being amortized on a straight-line basis over periods of 2 to 15 years
CY2022	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2021	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberExercised	36667	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceExercised	4.65
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	431314	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	195341	usd
CY2021	CODA	Other Incomes OtherIncomes	84942	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	CODA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesWeightedAverageGrantDateFairValue	4.65
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	39834	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4301221	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4947765	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10863674	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10804074	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	417673	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	505666	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11281347	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11309740	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.40
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.46
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1446835	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	61746	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	1385089	usd
CY2021	CODA	Paycheck Protection Program Loans PaycheckProtectionProgramLoans	648872	usd
CY2022	CODA	Erc Payroll Tax Credits ERCPayrollTaxCredits	88917	usd
CY2021	CODA	Erc Payroll Tax Credits ERCPayrollTaxCredits	701568	usd
CY2022	CODA	Other Incomes OtherIncomes	49058	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1595075	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1504986	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1152789	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-1092711	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	442286	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	412275	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	60077	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	50379	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	52089	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	42877	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	27533	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	24442	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3382108	usd
CY2021Q4	us-gaap	Goodwill Goodwill	3382108	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10537055	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10665602	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4704523	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4628501	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5832532	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6037101	usd
CY2022	us-gaap	Depreciation Depreciation	678652	usd
CY2021	us-gaap	Depreciation Depreciation	873694	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.65
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberForfeited	-4333	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	35501	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.65
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	307167	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.65
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	18631	usd
CY2021Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	63992	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	151217	usd
CY2022Q4	CODA	Employee Retention Credit Receivables EmployeeRetentionCreditReceivables	173213	usd
CY2021Q4	CODA	Employee Retention Credit Receivables EmployeeRetentionCreditReceivables	563627	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	343061	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	627619	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	544175	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1446835	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	561000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.65
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	561000	shares
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.65
CY2021	CODA	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice	4.65	shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberVested	185667	shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceVested	4.65
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	185667	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4.65
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	169332	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	4.65
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberExercised	169332	shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceExercised	4.65
CY2021	CODA	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesWeightedAverageGrantDateFairValue	4.65
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.65
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	8000	shares
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.65
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	383668	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.65
CY2021Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableOutstandingNumber	16335	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	367333	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	4.65
CY2022	CODA	Share Based Compensation Arrangements By Share Based Payment Award Options Vested In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedInPeriodWeightedAverageExercisePrice	4.65	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumberVested	183668	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Vested ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePriceVested	4.65
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	544175	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	281689	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	262486	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	211284	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	482595	usd
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsInPeriod	127500	shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodOutstandingWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodExercisableWeightedAverageGrantDateFairValue	8.80
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	127500	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodOutstandingWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodExercisableWeightedAverageGrantDateFairValue	8.80
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesOutstandingWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises Weighted Average Grant Date Fair Value Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesWeightedAverageGrantDateFairValueExercisable	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercises Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisesWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockOutstandingWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Weighted Average Grant Date Fair Value Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockWeightedAverageGrantDateFairValueExercisable	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingForfeitedInPeriod	5500	shares
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresOutstandingWeightedAverageGrantDateFairValue	8.80
CY2021	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValueExercisable	8.80
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	5500	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	8.80
CY2021Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNonvestedNumber	122000	shares
CY2021Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageGrantDateFairValue	8.80
CY2021Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue	8.80
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	122000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.80
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingGrantsInPeriod	64687	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodOutstandingWeightedAverageGrantDateFairValue	7.15
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodExercisableWeightedAverageGrantDateFairValue	7.15
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	64687	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.15
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingVestedInPeriod	-53733	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodOutstandingWeightedAverageGrantDateFairValue	5.05
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodExercisableWeightedAverageGrantDateFairValue	5.05
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	53733	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5.05
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Treasury Stockin Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingTreasuryStockinPeriod	5467	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockOutstandingWeightedAverageGrantDateFairValue	5.18
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Weighted Average Grant Date Fair Value Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockWeightedAverageGrantDateFairValueExercisable	5.18
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockInPeriod	5467	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Treasury Stock Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsTreasuryStockWeightedAverageGrantDateFairValue	5.18
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingForfeitedInPeriod	16981	shares
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresOutstandingWeightedAverageGrantDateFairValue	8.43
CY2022	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValueExercisable	8.43
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	16981	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	8.43
CY2022Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingNonvestedNumber	110506	shares
CY2022Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Outstanding Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedOutstandingWeightedAverageGrantDateFairValue	8.10
CY2022Q4	CODA	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue	8.10
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	110506	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	8.10
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	849580	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-25429	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	159900	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-4340	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	42021	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1005140	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16592	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-174026	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	288887	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-174026	usd
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	288887	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	831114	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	305479	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.106	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.184	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.037	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.009	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.032	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.030	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.162	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.058	pure
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	15930	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4830	usd
CY2022Q4	CODA	Deferred Tax Asset Restricted Stock Awards DeferredTaxAssetRestrictedStockAwards	272841	usd
CY2021Q4	CODA	Deferred Tax Asset Restricted Stock Awards DeferredTaxAssetRestrictedStockAwards	72970	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-17861	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-12124	usd
CY2022Q4	CODA	Deferred Tax Assets Foreign Research And Development Refunds DeferredTaxAssetsForeignResearchAndDevelopmentRefunds	-84381	usd
CY2021Q4	CODA	Deferred Tax Assets Foreign Research And Development Refunds DeferredTaxAssetsForeignResearchAndDevelopmentRefunds	18168	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	409100	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	148650	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	584529	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	243594	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	324719	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	166818	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	259810	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	76776	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	2246251	gbp
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	2819389	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	63559	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	63559	usd
CY2022Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	4000000	usd
CY2022	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0	usd
CY2021	us-gaap	Line Of Credit Facility Maximum Amount Outstanding During Period LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod	0	usd
CY2022	us-gaap	Revenues Revenues	22225803	usd
CY2022	us-gaap	Revenues Revenues	22225803	usd
CY2022	us-gaap	Revenues Revenues	22225803	usd
CY2021	us-gaap	Revenues Revenues	21331527	usd
CY2021	us-gaap	Revenues Revenues	21331527	usd
CY2021	us-gaap	Revenues Revenues	21331527	usd
CY2022	CODA	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributable	3070065	usd
CY2021	CODA	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributable	-654219	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1667059	usd
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2321278	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-3070065	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	654219	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4737124	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1667059	usd
CY2022	CODA	Employee Compensation Percentage EmployeeCompensationPercentage	0.04	pure
CY2022	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	138260	usd
CY2021	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	123215	usd

Files In Submission

Name	View Source	Status
coda-20221031_def.xml	Edgar Link	unprocessable
coda-20221031_lab.xml	Edgar Link	unprocessable
coda-20221031_cal.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
0001493152-23-002840-index-headers.html	Edgar Link	pending
0001493152-23-002840-index.html	Edgar Link	pending
0001493152-23-002840.txt	Edgar Link	pending
0001493152-23-002840-xbrl.zip	Edgar Link	pending
coda-20221031.xsd	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
coda-20221031_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CODA
Coda Octopus Group, Inc. Stock $coda

2023 Q1 Form 10-K Financial Statement

#000149315223002840 Filed on January 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CODA Coda Octopus Group, Inc. Stock $coda

2023 Q1 Form 10-K Financial Statement

#000149315223002840 Filed on January 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CODA
Coda Octopus Group, Inc. Stock $coda